PHARVARIS NV

PHARVARIS NV insider buying: COO Souverijns acquires 20,000 shares at €17.43, signaling confidence in the company’s B2 antagonist pipeline and potential upside for investors.

Inside PHARVARIS NV: Lu Peng’s 15,000‑share buy at $2.59 and sell at $40.13 reveal disciplined 10‑b5‑1 trading, low dilution risk, and growing investor confidence.

Insider glassman’s $32.00 purchase signals confidence in Pharvaris NV’s B2 antagonist pipeline and rising market momentum, hinting at future upside for investors.